Sun Pharma Advanced Research Company Q1 loss widens to Rs 79 cr

Total income of the company, however, rose to Rs 24.62 crore

Last Updated : Aug 05 2017 | 4:56 PM IST

Sun Pharma's research and drug discovery arm Sun Pharma Advanced Research Company (SPARC) on Saturday reported widening of net loss to Rs 78.84 crore for the first quarter ended June 30.

The company had posted a net loss of Rs 36.14 crore for the June quarter of 2016-17 fiscal, SPARC said in a filing to BSE.

Total income of the company, however, rose to Rs 24.62 crore as against Rs 24.50 crore for the same period a year ago.

SPARC was formed in 2007, when Sun Pharmaceutical Industries separated out its active projects in drug discovery and innovation into a new company.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Already subscribed? Log in

Subscribe to read the full story →

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

In-depth market analysis & insights with access to The Smart Investor

Ad-free Reading

Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

Access Business Standard across devices — mobile, tablet, or PC, via web or app

SAVE 25%

Subscribe for ₹2,700 / 1 Year

Connect with us on WhatsApp

Sun Pharma Advanced Research Company Q1 loss widens to Rs 79 cr

Total income of the company, however, rose to Rs 24.62 crore